ReP USP - Resultado da busca

Artigo de periodico
Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer (2011)
Fernandes, Bruno José Dumêt; Silva, Carolina de Miranda; Andrade, Jurandyr Moreira; Matthes, Ângelo do Carmo Silva; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Cancer Chemotherapy and Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEOPLASIAS MAMÁRIAS, FARMACOCINÉTICA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Bruno José Dumêt et al. Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer. Cancer Chemotherapy and Pharmacology, v. 68, n. 4, p. 897-904, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00280-011-1554-7. Acesso em: 04 maio 2024.
APA
Fernandes, B. J. D., Silva, C. de M., Andrade, J. M., Matthes, Â. do C. S., Coelho, E. B., & Lanchote, V. L. (2011). Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer. Cancer Chemotherapy and Pharmacology, 68( 4), 897-904. doi:10.1007/s00280-011-1554-7
NLM
Fernandes BJD, Silva C de M, Andrade JM, Matthes Â do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 maio 04 ] Available from: https://doi.org/10.1007/s00280-011-1554-7
Vancouver
Fernandes BJD, Silva C de M, Andrade JM, Matthes Â do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 maio 04 ] Available from: https://doi.org/10.1007/s00280-011-1554-7
Artigo de periodico
Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer (2011)
Fernandes, Bruno José Dumêt; Silva, Carolina de Miranda; Andrade, Jurandyr Moreira de; Matthes, Ângelo do Carmo Silva; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Cancer Chemotherapy and Pharmacology. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, FARMACOTERAPIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Bruno José Dumêt et al. Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer. Cancer Chemotherapy and Pharmacology, v. 68, n. 4, p. 897-904, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00280-011-1554-7. Acesso em: 04 maio 2024.
APA
Fernandes, B. J. D., Silva, C. de M., Andrade, J. M. de, Matthes, Â. do C. S., Coelho, E. B., & Lanchote, V. L. (2011). Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer. Cancer Chemotherapy and Pharmacology, 68( 4), 897-904. doi:10.1007/s00280-011-1554-7
NLM
Fernandes BJD, Silva C de M, Andrade JM de, Matthes Â do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 maio 04 ] Available from: https://doi.org/10.1007/s00280-011-1554-7
Vancouver
Fernandes BJD, Silva C de M, Andrade JM de, Matthes Â do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2024 maio 04 ] Available from: https://doi.org/10.1007/s00280-011-1554-7
Artigo de periodico
Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity (2011)
Lima, Renata Monteiro; Ferreira, Maria Augusta Drago; Carvalho, Maria de Jesus Ponte; Fernandes, Bruno José Dumêt; Takayanagu, Osvaldo Massaiti; Garcia, Hector Hugo; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, METABOLISMO, MEDICAMENTO (INTERAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Renata Monteiro et al. Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity. British Journal of Clinical Pharmacology, v. 71, n. 4, p. 528-535, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2125.2010.03874.x. Acesso em: 04 maio 2024.
APA
Lima, R. M., Ferreira, M. A. D., Carvalho, M. de J. P., Fernandes, B. J. D., Takayanagu, O. M., Garcia, H. H., et al. (2011). Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity. British Journal of Clinical Pharmacology, 71( 4), 528-535. doi:10.1111/j.1365-2125.2010.03874.x
NLM
Lima RM, Ferreira MAD, Carvalho M de JP, Fernandes BJD, Takayanagu OM, Garcia HH, Coelho EB, Lanchote VL. Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity [Internet]. British Journal of Clinical Pharmacology. 2011 ; 71( 4): 528-535.[citado 2024 maio 04 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03874.x
Vancouver
Lima RM, Ferreira MAD, Carvalho M de JP, Fernandes BJD, Takayanagu OM, Garcia HH, Coelho EB, Lanchote VL. Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity [Internet]. British Journal of Clinical Pharmacology. 2011 ; 71( 4): 528-535.[citado 2024 maio 04 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03874.x
Artigo de periodico
Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients (2009)
Silva, Carolina de Miranda; Fernandes, Bruno José Dumêt; Pereira, Maria Paula Marques; Silva, Lucienir Maria da; Donadi, Eduardo Antônio; Matthes, Ângelo do Carmo Silva; Andrade, Jurandyr Moreira de; Lanchote, Vera Lúcia
Source: Chirality. Unidades: FCFRP, FMRP
Subjects: NEOPLASIAS MAMÁRIAS, FARMACOTÉCNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carolina de Miranda et al. Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients. Chirality, v. 21, n. 3, p. 383-389, 2009Tradução . . Disponível em: https://doi.org/10.1002/chir.20596. Acesso em: 04 maio 2024.
APA
Silva, C. de M., Fernandes, B. J. D., Pereira, M. P. M., Silva, L. M. da, Donadi, E. A., Matthes, Â. do C. S., et al. (2009). Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients. Chirality, 21( 3), 383-389. doi:10.1002/chir.20596
NLM
Silva C de M, Fernandes BJD, Pereira MPM, Silva LM da, Donadi EA, Matthes Â do CS, Andrade JM de, Lanchote VL. Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients [Internet]. Chirality. 2009 ; 21( 3): 383-389.[citado 2024 maio 04 ] Available from: https://doi.org/10.1002/chir.20596
Vancouver
Silva C de M, Fernandes BJD, Pereira MPM, Silva LM da, Donadi EA, Matthes Â do CS, Andrade JM de, Lanchote VL. Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients [Internet]. Chirality. 2009 ; 21( 3): 383-389.[citado 2024 maio 04 ] Available from: https://doi.org/10.1002/chir.20596
Artigo de periodico
Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis (2009)
Silva, Carolina Miranda; Fernandes, Bruno José Dumêt; Donadi, Eduardo Antônio; Silva, Lucienir Maria da; Coelho, Eduardo Barbosa; Dantas, Márcio; Marques, Maria Paula; Lanchote, Vera Lúcia
Source: Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, NEFRITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carolina Miranda et al. Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis. Journal of Clinical Pharmacology, v. 49, n. 8, p. 965-972, 2009Tradução . . Acesso em: 04 maio 2024.
APA
Silva, C. M., Fernandes, B. J. D., Donadi, E. A., Silva, L. M. da, Coelho, E. B., Dantas, M., et al. (2009). Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis. Journal of Clinical Pharmacology, 49( 8), 965-972.
NLM
Silva CM, Fernandes BJD, Donadi EA, Silva LM da, Coelho EB, Dantas M, Marques MP, Lanchote VL. Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis. Journal of Clinical Pharmacology. 2009 ; 49( 8): 965-972.[citado 2024 maio 04 ]
Vancouver
Silva CM, Fernandes BJD, Donadi EA, Silva LM da, Coelho EB, Dantas M, Marques MP, Lanchote VL. Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis. Journal of Clinical Pharmacology. 2009 ; 49( 8): 965-972.[citado 2024 maio 04 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em